Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Hammer AE"" wg kryterium: Autor


Tytuł :
Efficacy and Safety of Subcutaneous Belimumab in Anti-Double-Stranded DNA-Positive, Hypocomplementemic Patients With Systemic Lupus Erythematosus.
Autorzy :
Doria A; University of Padua, Padua, Italy.
Stohl W; University of Southern California, Los Angeles.
Schwarting A; University Medical Center of Johannes Gutenberg University, Mainz, Germany.
Okada M; St. Luke's International University, Tokyo, Japan.
Scheinberg M; Rheumatology Hospital Abreu Sodre, São Paulo, Brazil.
van Vollenhoven R; Amsterdam Rheumatology and Immunology Center, Amsterdam, The Netherlands.
Hammer AE; GlaxoSmithKline, Research Triangle Park, North Carolina.
Groark J; GlaxoSmithKline, Collegeville, Pennsylvania.
Bass D; GlaxoSmithKline, Collegeville, Pennsylvania.
Fox NL; GlaxoSmithKline, Rockville, Maryland.
Roth D; GlaxoSmithKline, Collegeville, Pennsylvania.
Gordon D; GlaxoSmithKline, Collegeville, Pennsylvania.
Pokaż więcej
Źródło :
Arthritis & rheumatology (Hoboken, N.J.) [Arthritis Rheumatol] 2018 Aug; Vol. 70 (8), pp. 1256-1264. Date of Electronic Publication: 2018 Jun 15.
Typ publikacji :
Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms :
Antibodies, Antinuclear/*blood
Antibodies, Monoclonal, Humanized/*administration & dosage
Complement C3/*deficiency
DNA/*immunology
Lupus Erythematosus, Systemic/*drug therapy
Adult ; Antibodies, Antinuclear/immunology ; Double-Blind Method ; Female ; Humans ; Injections, Subcutaneous ; Intention to Treat Analysis ; Lupus Erythematosus, Systemic/blood ; Lupus Erythematosus, Systemic/immunology ; Male ; Severity of Illness Index ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Efficacy and Safety of Subcutaneous Belimumab in Systemic Lupus Erythematosus: A Fifty-Two-Week Randomized, Double-Blind, Placebo-Controlled Study.
Autorzy :
Stohl W; University of Southern California, Los Angeles.
Schwarting A; Acura Kliniken Rheinland-Pfalz AG, Bad Kreuznach, Germany.
Okada M; St. Luke's International Hospital, Tokyo, Japan.
Scheinberg M; Rheumatology Hospital Abreu Sodre, São Paulo, Brazil.
Doria A; University of Padua, Padua, Italy.
Hammer AE; GlaxoSmithKline, Research Triangle Park, North Carolina.
Kleoudis C; Parexel, Raleigh-Durham, North Carolina.
Groark J; GlaxoSmithKline, Philadelphia, Pennsylvania.
Bass D; GlaxoSmithKline, Philadelphia, Pennsylvania.
Fox NL; GlaxoSmithKline, Rockville, Maryland.
Roth D; GlaxoSmithKline, Philadelphia, Pennsylvania.
Gordon D; GlaxoSmithKline, Philadelphia, Pennsylvania.
Pokaż więcej
Źródło :
Arthritis & rheumatology (Hoboken, N.J.) [Arthritis Rheumatol] 2017 May; Vol. 69 (5), pp. 1016-1027. Date of Electronic Publication: 2017 Apr 07.
Typ publikacji :
Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms :
Antibodies, Monoclonal, Humanized/*therapeutic use
Immunosuppressive Agents/*therapeutic use
Lupus Erythematosus, Systemic/*drug therapy
Adrenal Cortex Hormones/administration & dosage ; Adult ; Disease Progression ; Double-Blind Method ; Female ; Humans ; Immunoglobulin G/immunology ; Immunologic Deficiency Syndromes/chemically induced ; Immunologic Deficiency Syndromes/immunology ; Infusions, Subcutaneous ; Male ; Middle Aged ; Odds Ratio ; Proportional Hazards Models ; Severity of Illness Index ; Therapeutics ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Cumulative Corticosteroid Dose Over Fifty-Two Weeks in Patients With Systemic Lupus Erythematosus: Pooled Analyses From the Phase III Belimumab Trials.
Autorzy :
van Vollenhoven RF; Academic Medical Center, Amsterdam, The Netherlands.
Petri M; Johns Hopkins University School of Medicine, Baltimore, Maryland.
Wallace DJ; Cedars-Sinai Medical Center and University of California, Los Angeles David Geffen School of Medicine, Los Angeles.
Roth DA; GlaxoSmithKline, Research Triangle Park, North Carolina.
Molta CT; GlaxoSmithKline, Philadelphia, Pennsylvania.
Hammer AE; GlaxoSmithKline, Research Triangle Park, North Carolina.
Tang Y; GlaxoSmithKline, Research Triangle Park, North Carolina.
Thompson A; GlaxoSmithKline, Research Triangle Park, North Carolina.
Pokaż więcej
Źródło :
Arthritis & rheumatology (Hoboken, N.J.) [Arthritis Rheumatol] 2016 Sep; Vol. 68 (9), pp. 2184-92.
Typ publikacji :
Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms :
Adrenal Cortex Hormones/*administration & dosage
Antibodies, Monoclonal, Humanized/*therapeutic use
Immunosuppressive Agents/*therapeutic use
Lupus Erythematosus, Systemic/*drug therapy
Adult ; Female ; Humans ; Male ; Time Factors
Czasopismo naukowe
Tytuł :
Elevated BLyS levels in patients with systemic lupus erythematosus: Associated factors and responses to belimumab.
Autorzy :
Roth DA; Research and Development, GlaxoSmithKline, Philadelphia, PA, USA .
Thompson A; Research and Development, GlaxoSmithKline, Research Triangle Park, NC, USA.
Tang Y; Research and Development, GlaxoSmithKline, Research Triangle Park, NC, USA.
Hammer AE; Research and Development, GlaxoSmithKline, Research Triangle Park, NC, USA.
Molta CT; Research and Development, GlaxoSmithKline, Philadelphia, PA, USA.
Gordon D; Research and Development, GlaxoSmithKline, Philadelphia, PA, USA.
Pokaż więcej
Źródło :
Lupus [Lupus] 2016 Apr; Vol. 25 (4), pp. 346-54. Date of Electronic Publication: 2015 Sep 18.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Antibodies, Monoclonal, Humanized/*therapeutic use
B-Cell Activating Factor/*blood
Immunosuppressive Agents/*therapeutic use
Lupus Erythematosus, Systemic/*blood
Lupus Erythematosus, Systemic/*drug therapy
Adult ; Antibodies, Monoclonal, Humanized/adverse effects ; B-Cell Activating Factor/immunology ; Biomarkers/blood ; Chi-Square Distribution ; Disease Progression ; Female ; Humans ; Immunosuppressive Agents/adverse effects ; Logistic Models ; Lupus Erythematosus, Systemic/diagnosis ; Lupus Erythematosus, Systemic/immunology ; Male ; Middle Aged ; Odds Ratio ; Predictive Value of Tests ; Proportional Hazards Models ; Risk Factors ; Time Factors ; Treatment Outcome ; Up-Regulation
Czasopismo naukowe
Tytuł :
Lamotrigine extended-release as adjunctive therapy with optional conversion to monotherapy in older adults with epilepsy.
Autorzy :
Wechsler RT; Idaho Comprehensive Epilepsy Center, United States. Electronic address: .
Leroy R; Texas Epilepsy Group, Dallas, TX, United States.
Van Cott A; University of Pittsburgh and VA Pittsburgh Healthcare System, United States.
Hammer AE; GlaxoSmithKline, United States.
Vuong A; GlaxoSmithKline, United States.
Huffman R; GlaxoSmithKline, United States.
VanLandingham K; GlaxoSmithKline, United States.
Messenheimer JA; GlaxoSmithKline, United States.
Pokaż więcej
Źródło :
Epilepsy research [Epilepsy Res] 2014 Aug; Vol. 108 (6), pp. 1128-36. Date of Electronic Publication: 2014 May 14.
Typ publikacji :
Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Anticonvulsants/*administration & dosage
Epilepsy/*drug therapy
Triazines/*administration & dosage
Aged ; Aged, 80 and over ; Anticonvulsants/adverse effects ; Delayed-Action Preparations ; Drug Therapy, Combination ; Epilepsy/physiopathology ; Female ; Humans ; Lamotrigine ; Male ; Seizures/drug therapy ; Seizures/physiopathology ; Treatment Outcome ; Triazines/adverse effects
Czasopismo naukowe
Tytuł :
Long-term tolerability and safety of lamotrigine extended-release: pooled analysis of three clinical trials.
Autorzy :
Biton V; Arkansas Epilepsy Program, Little Rock, AR 72205, USA. />Shneker BF
Naritoku D
Hammer AE
Vuong A
Caldwell PT
Messenheimer JA
Pokaż więcej
Źródło :
Clinical drug investigation [Clin Drug Investig] 2013 May; Vol. 33 (5), pp. 359-64.
Typ publikacji :
Journal Article; Meta-Analysis; Research Support, Non-U.S. Gov't
MeSH Terms :
Anticonvulsants/*therapeutic use
Seizures/*drug therapy
Triazines/*therapeutic use
Anticonvulsants/administration & dosage ; Anticonvulsants/adverse effects ; Chemistry, Pharmaceutical ; Delayed-Action Preparations ; Double-Blind Method ; Drug Administration Schedule ; Humans ; Lamotrigine ; Randomized Controlled Trials as Topic ; Risk Assessment ; Risk Factors ; Seizures/diagnosis ; Seizures/physiopathology ; Time Factors ; Treatment Outcome ; Triazines/administration & dosage ; Triazines/adverse effects
Czasopismo naukowe
Tytuł :
Analysis of three lamotrigine extended-release clinical trials: comparison of pragmatic ITT and LOCF methodologies.
Autorzy :
French JA; NYU Comprehensive Epilepsy Center, 223 E. 34th St., New York, NY 10016, United States. />Hammer AE
Vuong A
Messenheimer JA
Pokaż więcej
Źródło :
Epilepsy research [Epilepsy Res] 2012 Aug; Vol. 101 (1-2), pp. 141-7. Date of Electronic Publication: 2012 Apr 10.
Typ publikacji :
Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial
MeSH Terms :
Research Design*
Anticonvulsants/*therapeutic use
Epilepsy/*drug therapy
Randomized Controlled Trials as Topic/*methods
Triazines/*therapeutic use
Adolescent ; Adult ; Aged ; Anticonvulsants/administration & dosage ; Delayed-Action Preparations ; Dose-Response Relationship, Drug ; Double-Blind Method ; Female ; Humans ; Lamotrigine ; Male ; Middle Aged ; Patient Compliance ; Seizures/prevention & control ; Treatment Outcome ; Triazines/administration & dosage ; Young Adult
Czasopismo naukowe
Tytuł :
Lamotrigine XR conversion to monotherapy: first study using a historical control group.
Autorzy :
French JA; NYU Comprehensive Epilepsy Center, New York, NY 10016, USA. />Temkin NR
Shneker BF
Hammer AE
Caldwell PT
Messenheimer JA
Pokaż więcej
Źródło :
Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics [Neurotherapeutics] 2012 Jan; Vol. 9 (1), pp. 176-84.
Typ publikacji :
Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; Review
MeSH Terms :
Anticonvulsants/*therapeutic use
Epilepsies, Partial/*drug therapy
Triazines/*therapeutic use
Adolescent ; Adult ; Aged ; Aged, 80 and over ; Dose-Response Relationship, Drug ; Double-Blind Method ; Drug Administration Schedule ; Drug Delivery Systems/methods ; Female ; Follow-Up Studies ; Humans ; International Cooperation ; Lamotrigine ; Male ; Middle Aged ; Treatment Outcome ; Valproic Acid/therapeutic use ; Young Adult
Czasopismo naukowe
Tytuł :
Effects of lamotrigine compared with levetiracetam on anger, hostility, and total mood in patients with partial epilepsy.
Autorzy :
Labiner DM; Department of Neurology, University of Arizona, Tucson, Arizona 85724, USA. />Ettinger AB
Fakhoury TA
Chung SS
Shneker B
Tatum Iv WO
Mitchell Miller J
Vuong A
Hammer AE
Messenheimer JA
Pokaż więcej
Źródło :
Epilepsia [Epilepsia] 2009 Mar; Vol. 50 (3), pp. 434-42. Date of Electronic Publication: 2008 Nov 04.
Typ publikacji :
Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms :
Hostility*
Affect/*drug effects
Anger/*drug effects
Anticonvulsants/*therapeutic use
Epilepsies, Partial/*drug therapy
Piracetam/*analogs & derivatives
Triazines/*therapeutic use
Adult ; Anticonvulsants/adverse effects ; Dose-Response Relationship, Drug ; Double-Blind Method ; Drug Administration Schedule ; Drug Therapy, Combination ; Female ; Humans ; Lamotrigine ; Levetiracetam ; Male ; Middle Aged ; Personality Inventory/statistics & numerical data ; Piracetam/adverse effects ; Piracetam/therapeutic use ; Psychometrics ; Triazines/adverse effects
Czasopismo naukowe
Tytuł :
Lamotrigine monotherapy for newly diagnosed typical absence seizures in children.
Autorzy :
Holmes GL; Neuroscience Center at Dartmouth, Dartmouth Medical School, Lebanon, NH, USA. />Frank LM
Sheth RD
Philbrook B
Wooten JD
Vuong A
Kerls S
Hammer AE
Messenheimer J
Pokaż więcej
Źródło :
Epilepsy research [Epilepsy Res] 2008 Dec; Vol. 82 (2-3), pp. 124-32. Date of Electronic Publication: 2008 Sep 07.
Typ publikacji :
Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Anticonvulsants/*therapeutic use
Epilepsy, Absence/*drug therapy
Triazines/*therapeutic use
Anticonvulsants/administration & dosage ; Anticonvulsants/adverse effects ; Child ; Child, Preschool ; Electroencephalography/drug effects ; Female ; Headache/etiology ; Humans ; Lamotrigine ; Male ; Medical Records ; Monitoring, Ambulatory ; Treatment Outcome ; Triazines/administration & dosage ; Triazines/adverse effects
Czasopismo naukowe
Tytuł :
Steady-state pharmacokinetics of lamotrigine when converting from a twice-daily immediate-release to a once-daily extended-release formulation in subjects with epilepsy (The COMPASS Study).
Autorzy :
Tompson DJ; GlaxoSmithKline, New Frontiers Science Park, Harlow, Essex, United Kingdom. />Ali I
Oliver-Willwong R
Job S
Zhu L
Lemme F
Hammer AE
Vuong A
Messenheimer JA
Pokaż więcej
Źródło :
Epilepsia [Epilepsia] 2008 Mar; Vol. 49 (3), pp. 410-7. Date of Electronic Publication: 2007 Sep 06.
Typ publikacji :
Clinical Trial; Comparative Study; Journal Article; Multicenter Study
MeSH Terms :
Anticonvulsants/*pharmacokinetics
Epilepsy/*drug therapy
Triazines/*pharmacokinetics
Administration, Oral ; Adolescent ; Adult ; Aged ; Aged, 80 and over ; Anticonvulsants/adverse effects ; Anticonvulsants/blood ; Area Under Curve ; Biological Availability ; Delayed-Action Preparations ; Dizziness/chemically induced ; Dose-Response Relationship, Drug ; Drug Administration Schedule ; Drug Therapy, Combination ; Epilepsy/blood ; Epilepsy/psychology ; Female ; Headache/chemically induced ; Humans ; Lamotrigine ; Least-Squares Analysis ; Male ; Middle Aged ; Patient Satisfaction ; Time Factors ; Treatment Outcome ; Triazines/adverse effects ; Triazines/blood ; Vomiting/chemically induced
Czasopismo naukowe
Tytuł :
Relative influences of adjunctive topiramate and adjunctive lamotrigine on scanning and the effective field of view.
Autorzy :
Mills KC; Profile Associates, Chapel Hill, NC, United States. />Drazkowski JF
Hammer AE
Caldwell PT
Kustra RP
Blum DE
Pokaż więcej
Źródło :
Epilepsy research [Epilepsy Res] 2008 Feb; Vol. 78 (2-3), pp. 140-6. Date of Electronic Publication: 2007 Dec 21.
Typ publikacji :
Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms :
Anticonvulsants/*adverse effects
Epilepsy/*complications
Fructose/*analogs & derivatives
Triazines/*adverse effects
Vision Disorders/*chemically induced
Visual Fields/*drug effects
Adolescent ; Adult ; Aged ; Aged, 80 and over ; Anticonvulsants/therapeutic use ; Cognition/drug effects ; Data Interpretation, Statistical ; Double-Blind Method ; Drug Therapy, Combination ; Epilepsy/drug therapy ; Female ; Fructose/adverse effects ; Fructose/therapeutic use ; Humans ; Lamotrigine ; Male ; Middle Aged ; Neuropsychological Tests ; Seizures/drug therapy ; Seizures/epidemiology ; Topiramate ; Triazines/therapeutic use ; Vision Disorders/psychology ; Visual Perception/drug effects
Czasopismo naukowe
Tytuł :
Depressive symptoms in epilepsy: prevalence, impact, aetiology, biological correlates and effect of treatment with antiepileptic drugs.
Autorzy :
Miller JM; GlaxoSmithKline, Research Triangle Park, North Carolina 27709, USA. />Kustra RP
Vuong A
Hammer AE
Messenheimer JA
Pokaż więcej
Źródło :
Drugs [Drugs] 2008; Vol. 68 (11), pp. 1493-509.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Anticonvulsants*/therapeutic use
Depression*/drug therapy
Depression*/etiology
Epilepsy*/complications
Epilepsy*/drug therapy
Epilepsy*/epidemiology
Humans ; Prevalence
Czasopismo naukowe
Tytuł :
Effects of lamotrigine on mood in older adults with epilepsy and co-morbid depressive symptoms: an open-label, multicentre, prospective study.
Autorzy :
Fakhoury TA; Department of Neurology, University of Kentucky, Lexington, Kentucky 40536, USA.
Miller JM
Hammer AE
Vuong A
Pokaż więcej
Źródło :
Drugs & aging [Drugs Aging] 2008; Vol. 25 (11), pp. 955-62.
Typ publikacji :
Clinical Trial; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
MeSH Terms :
Anticonvulsants/*therapeutic use
Depressive Disorder/*complications
Depressive Disorder/*psychology
Epilepsy/*drug therapy
Epilepsy/*psychology
Triazines/*therapeutic use
Affect/drug effects ; Age of Onset ; Aged ; Aged, 80 and over ; Data Interpretation, Statistical ; Depressive Disorder/drug therapy ; Epilepsy/complications ; Female ; Humans ; Lamotrigine ; Male ; Middle Aged ; Prospective Studies ; Psychiatric Status Rating Scales ; Quality of Life ; Seizures/epidemiology ; Seizures/prevention & control
Czasopismo naukowe
Tytuł :
Conversion to lamotrigine monotherapy from valproate monotherapy in older adolescent patients with epilepsy.
Autorzy :
Baumann RJ; University of Kentucky, Lexington KY, USA.
Fakhoury TA
Kustra RP
Vuong A
Hammer AE
Messenheimer JA
Pokaż więcej
Źródło :
Current medical research and opinion [Curr Med Res Opin] 2007 Oct; Vol. 23 (10), pp. 2461-5.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Anticonvulsants/*therapeutic use
Epilepsy/*drug therapy
Triazines/*therapeutic use
Valproic Acid/*therapeutic use
Adolescent ; Adult ; Anticonvulsants/adverse effects ; Anticonvulsants/blood ; Dose-Response Relationship, Drug ; Female ; Humans ; Lamotrigine ; Male ; Triazines/adverse effects ; Triazines/blood
Czasopismo naukowe
Tytuł :
Double-blind, placebo-controlled trial of lamotrigine in combination with other medications for neuropathic pain.
Autorzy :
Silver M; GlaxoSmithKline, Five Moore Drive, Research Triangle Park, NC 277709, USA. />Blum D
Grainger J
Hammer AE
Quessy S
Pokaż więcej
Źródło :
Journal of pain and symptom management [J Pain Symptom Manage] 2007 Oct; Vol. 34 (4), pp. 446-54. Date of Electronic Publication: 2007 Jul 26.
Typ publikacji :
Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms :
Hyperalgesia/*drug therapy
Neuralgia/*drug therapy
Pain Measurement/*drug effects
Triazines/*administration & dosage
Analgesics/administration & dosage ; Double-Blind Method ; Drug Therapy, Combination ; Female ; Humans ; Lamotrigine ; Male ; Middle Aged ; Placebo Effect ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Assessment of tolerability in elderly patients: changing to lamotrigine therapy.
Autorzy :
Evans BK; Northern Michigan Neurology, Traverse City, Michigan 49684-2340, USA. />Kustra RP
Hammer AE
Pokaż więcej
Źródło :
The American journal of geriatric pharmacotherapy [Am J Geriatr Pharmacother] 2007 Jun; Vol. 5 (2), pp. 112-9.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Anticonvulsants/*adverse effects
Anticonvulsants/*therapeutic use
Epilepsy/*drug therapy
Triazines/*adverse effects
Triazines/*therapeutic use
Affect/drug effects ; Aged ; Aged, 80 and over ; Drug Therapy, Combination ; Epilepsy/psychology ; Female ; Humans ; Lamotrigine ; Male ; Middle Aged ; Quality of Life
Czasopismo naukowe
Tytuł :
Lamotrigine in patients with epilepsy and comorbid depressive symptoms.
Autorzy :
Fakhoury TA; Department of Neurology, University of Kentucky, Lexington, KY, USA. />Barry JJ
Mitchell Miller J
Hammer AE
Vuong A
Pokaż więcej
Źródło :
Epilepsy & behavior : E&B [Epilepsy Behav] 2007 Feb; Vol. 10 (1), pp. 155-62. Date of Electronic Publication: 2006 Dec 12.
Typ publikacji :
Controlled Clinical Trial; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
MeSH Terms :
Anticonvulsants/*therapeutic use
Depression/*drug therapy
Depression/*epidemiology
Epilepsy/*drug therapy
Epilepsy/*epidemiology
Triazines/*therapeutic use
Adolescent ; Adult ; Aged ; Aged, 80 and over ; Drug Evaluation ; Female ; Follow-Up Studies ; Humans ; Lamotrigine ; Male ; Middle Aged ; Psychiatric Status Rating Scales ; Psychometrics ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Effect of lamotrigine on depressive symptoms in adult patients with epilepsy.
Autorzy :
Ettinger AB; North Shore-LIJ Comprehensive Epilepsy Centers, Long Island Jewish Medical Center, EEG Lab, 270-05 76th Avenue, New Hyde Park, NY, USA. />Kustra RP
Hammer AE
Pokaż więcej
Źródło :
Epilepsy & behavior : E&B [Epilepsy Behav] 2007 Feb; Vol. 10 (1), pp. 148-54. Date of Electronic Publication: 2006 Oct 27.
Typ publikacji :
Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms :
Anticonvulsants/*therapeutic use
Depression/*drug therapy
Depression/*etiology
Epilepsy/*complications
Triazines/*therapeutic use
Adult ; Affect/drug effects ; Analysis of Variance ; Double-Blind Method ; Epilepsy/drug therapy ; Female ; Humans ; Lamotrigine ; Male ; Middle Aged ; Prospective Studies ; Psychiatric Status Rating Scales ; Treatment Outcome
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies